$YTENQ
YIELD10 BIOSCIENCE, INC.

2022 Q3 Form 10-Q Financial Statement

#000112170222000039 Filed on August 10, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $111.0K $103.0K $149.0K
YoY Change 20.65% -40.8% -23.98%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.518M $1.523M $1.707M
YoY Change -1.87% -5.05% 19.2%
% of Gross Profit
Research & Development $2.083M $2.016M $1.763M
YoY Change 27.32% 22.11% 49.41%
% of Gross Profit
Depreciation & Amortization $69.00K $69.00K $59.00K
YoY Change 21.05% 18.97% 9.26%
% of Gross Profit
Operating Expenses $1.518M $1.523M $1.707M
YoY Change -1.87% -5.05% 19.2%
Operating Profit -$3.490M -$3.436M -$3.321M
YoY Change 12.91% 11.52% 30.13%
Interest Expense $0.00
YoY Change -100.0%
% of Operating Profit
Other Income/Expense, Net $10.00K $2.000K -$1.000K
YoY Change -98.57% 0.0%
Pretax Income -$3.480M -$3.434M -$3.322M
YoY Change 45.48% 11.46% 30.12%
Income Tax $9.000K $9.000K $9.000K
% Of Pretax Income
Net Earnings -$3.489M -$3.443M -$3.331M
YoY Change 45.5% 11.35% 30.07%
Net Earnings / Revenue -3143.24% -3342.72% -2235.57%
Basic Earnings Per Share -$0.71 -$0.70 -$0.68
Diluted Earnings Per Share -$0.71 -$0.70 -$0.68
COMMON SHARES
Basic Shares Outstanding 4.914M shares 4.900M shares 4.889M shares
Diluted Shares Outstanding 4.925M shares 4.900M shares 4.889M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.405M $10.16M $12.74M
YoY Change -60.02% -50.6% -41.55%
Cash & Equivalents $3.922M $3.180M $2.128M
Short-Term Investments $3.483M $6.978M $10.61M
Other Short-Term Assets $414.0K $483.0K $451.0K
YoY Change -10.39% -5.11% -9.8%
Inventory
Prepaid Expenses
Receivables $37.00K $35.00K $124.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $7.895M $10.70M $13.38M
YoY Change -58.57% -49.47% -40.63%
LONG-TERM ASSETS
Property, Plant & Equipment $840.0K $895.0K $945.0K
YoY Change -6.98% -5.69% -2.38%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $210.0K $248.0K $261.0K
YoY Change -24.46% -9.82% -11.53%
Total Long-Term Assets $3.377M $3.569M $3.729M
YoY Change -13.23% -11.33% -25.98%
TOTAL ASSETS
Total Short-Term Assets $7.895M $10.70M $13.38M
Total Long-Term Assets $3.377M $3.569M $3.729M
Total Assets $11.27M $14.27M $17.10M
YoY Change -50.88% -43.38% -37.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $104.0K $24.00K $24.00K
YoY Change 131.11% -76.24% -78.38%
Accrued Expenses $1.163M $1.059M $823.0K
YoY Change 3.65% -14.39% -2.02%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.826M $1.627M $1.376M
YoY Change 9.6% -10.75% -3.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.226M $2.375M $5.000K
YoY Change 24633.33% 23650.0% -58.33%
Total Long-Term Liabilities $2.226M $2.375M $5.000K
YoY Change 24633.33% 23650.0% -58.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.826M $1.627M $1.376M
Total Long-Term Liabilities $2.226M $2.375M $5.000K
Total Liabilities $4.052M $4.002M $3.893M
YoY Change -9.11% -15.71% -12.99%
SHAREHOLDERS EQUITY
Retained Earnings -$396.4M -$392.9M -$389.5M
YoY Change 3.46% 3.19% 3.12%
Common Stock $403.8M $403.4M $402.9M
YoY Change 0.51% 0.51% 0.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.220M $10.27M $13.21M
YoY Change
Total Liabilities & Shareholders Equity $11.27M $14.27M $17.10M
YoY Change -50.88% -43.38% -37.96%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$3.489M -$3.443M -$3.331M
YoY Change 45.5% 11.35% 30.07%
Depreciation, Depletion And Amortization $69.00K $69.00K $59.00K
YoY Change 21.05% 18.97% 9.26%
Cash From Operating Activities -$2.702M -$2.538M -$3.102M
YoY Change 35.64% 18.82% 17.63%
INVESTING ACTIVITIES
Capital Expenditures -$21.00K -$19.00K $114.0K
YoY Change 90.91% -47.22% 12.87%
Acquisitions
YoY Change
Other Investing Activities $3.515M $3.635M $26.00K
YoY Change 245.62% -571.47% -98.78%
Cash From Investing Activities $3.494M $3.616M -$88.00K
YoY Change 247.32% -548.08% -104.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -23.00K 0.000 -$14.00K
YoY Change 15.0% -100.0% -100.09%
NET CHANGE
Cash From Operating Activities -2.702M -2.538M -$3.102M
Cash From Investing Activities 3.494M 3.616M -$88.00K
Cash From Financing Activities -23.00K 0.000 -$14.00K
Net Change In Cash 769.0K 1.078M -$3.201M
YoY Change -176.44% -136.58% -121.12%
FREE CASH FLOW
Cash From Operating Activities -$2.702M -$2.538M -$3.102M
Capital Expenditures -$21.00K -$19.00K $114.0K
Free Cash Flow -$2.681M -$2.519M -$3.216M
YoY Change 35.34% 19.95% 17.46%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001121702
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Entity Shell Company
EntityShellCompany
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33133
dei Entity Registrant Name
EntityRegistrantName
YIELD10 BIOSCIENCE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-3158289
dei Entity Address Address Line1
EntityAddressAddressLine1
19 Presidential Way
dei Entity Address City Or Town
EntityAddressCityOrTown
Woburn
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
01801
dei City Area Code
CityAreaCode
617
dei Local Phone Number
LocalPhoneNumber
583-1700
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
YTEN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
4914121 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3180000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5329000 usd
CY2022Q2 us-gaap Short Term Investments
ShortTermInvestments
6978000 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
10661000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
35000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
164000 usd
CY2022Q2 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
28000 usd
CY2021Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
34000 usd
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
483000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
436000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
10704000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
16624000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
264000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
264000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
895000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
890000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2162000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2354000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
248000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
283000 usd
CY2022Q2 us-gaap Assets
Assets
14273000 usd
CY2021Q4 us-gaap Assets
Assets
20415000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
24000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
83000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1059000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1136000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
544000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
514000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1627000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1733000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2375000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2656000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
4002000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
4389000 usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4901246 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4901246 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4881851 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4881851 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
49000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
49000 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
403347000 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
402283000 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-220000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-175000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-392905000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-386131000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
10271000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
16026000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
14273000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20415000 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
103000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
174000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
252000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
370000 usd
CY2022Q2 yten Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
2016000 usd
CY2021Q2 yten Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
1651000 usd
yten Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
3779000 usd
yten Cost Of Revenue Research And Development Expenses
CostOfRevenueResearchAndDevelopmentExpenses
2967000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1523000 usd
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1604000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3230000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3036000 usd
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
3539000 usd
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
3255000 usd
us-gaap Costs And Expenses
CostsAndExpenses
7009000 usd
us-gaap Costs And Expenses
CostsAndExpenses
6003000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3436000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3081000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-6757000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5633000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
2000 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
0 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3434000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3081000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6756000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5634000 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9000 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
19000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-3443000 usd
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.70
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-3092000 usd
us-gaap Net Income Loss
NetIncomeLoss
-6774000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5653000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5653000 usd
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.70
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.64
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.64
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.38
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.38
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.23
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.23
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4900298 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4900298 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4868156 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4868156 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4894638 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4894638 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4583723 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4583723 shares
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-3443000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-3092000 usd
us-gaap Net Income Loss
NetIncomeLoss
-6774000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5653000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5653000 usd
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1000 usd
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-22000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1000 usd
CY2022Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-26000 usd
CY2021Q2 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
6000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-23000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
6000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
5000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-27000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
6000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-45000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3470000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3086000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6819000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5647000 usd
us-gaap Net Income Loss
NetIncomeLoss
-6774000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5653000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5653000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
128000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
108000 usd
yten Charge For Company Common Stock Match
ChargeForCompanyCommonStockMatch
76000 usd
yten Charge For Company Common Stock Match
ChargeForCompanyCommonStockMatch
69000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1011000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
739000 usd
yten Noncash Lease Expense Income
NoncashLeaseExpenseIncome
192000 usd
yten Noncash Lease Expense Income
NoncashLeaseExpenseIncome
175000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
19000 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
14000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-129000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-6000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
11000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
37000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-24000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-59000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
41000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-80000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-69000 usd
yten Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-251000 usd
yten Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-223000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5640000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5640000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4776000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4776000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
133000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
136000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
710000 usd
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
3891000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
4371000 usd
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
5250000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3528000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3528000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1223000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1223000 usd
yten Proceeds From Warrant Exercises Net
ProceedsFromWarrantExercisesNet
0 usd
yten Proceeds From Warrant Exercises Net
ProceedsFromWarrantExercisesNet
3856000 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
11993000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
14000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
83000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-14000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-14000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15766000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15766000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-23000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2149000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12218000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5593000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3687000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3444000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15905000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
13211000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
489000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
41000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-27000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-3443000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
10271000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
23094000 usd
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
414000 usd
CY2021Q2 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
40000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
6000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-3092000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
20462000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
16026000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1012000 usd
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
66000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
14000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-45000 usd
us-gaap Net Income Loss
NetIncomeLoss
-6774000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
10271000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
9532000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
749000 usd
us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
62000 usd
us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3856000 usd
us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
0 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
83000 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
11993000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
6000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5653000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
20462000 usd
CY2022Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
10158000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3180000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5329000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
264000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
264000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3444000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5593000 usd
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
264000 usd
CY2022Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
264000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:12pt;padding-right:4.5pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of grant revenue and expenses during the reporting periods. Actual results could differ from those estimates.</span></div>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-bottom:9pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentrations of credit risk primarily consist of cash, cash equivalents, restricted cash, short-term investments and accounts receivable. The Company has historically invested its cash in highly rated money market funds, corporate debt, federal agency notes and U.S. treasury notes. Investments, when purchased, are acquired in accordance with the Company’s investment policy which establishes a concentration limit per issuer.</span></div>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2294407 shares
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2912534 shares
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
10669000 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
0 usd
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
8000 usd
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
10661000 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
381000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
452000 usd
CY2022Q2 yten Accrued Lease Cost
AccruedLeaseCost
61000 usd
CY2021Q4 yten Accrued Lease Cost
AccruedLeaseCost
71000 usd
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
267000 usd
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
264000 usd
CY2022Q2 yten Accrued Field Trials And Related Expenses Current
AccruedFieldTrialsAndRelatedExpensesCurrent
215000 usd
CY2021Q4 yten Accrued Field Trials And Related Expenses Current
AccruedFieldTrialsAndRelatedExpensesCurrent
97000 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
135000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
252000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1059000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1136000 usd
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
-488000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1011000 usd
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
415000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
739000 usd
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
244092 shares
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
166702 shares
CY2022Q1 yten Share Based Compensation Arrangement By Share Based Payment Award Additional Shares Authorized Percent
ShareBasedCompensationArrangementByShareBasedPaymentAwardAdditionalSharesAuthorizedPercent
0.05
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
300000 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
29964 shares
us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
2952 shares
yten Payment Tax Withholding Share Based Payment Arrangement Excluding Employer Amount
PaymentTaxWithholdingShareBasedPaymentArrangementExcludingEmployerAmount
13000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
367000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
749000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
771000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
793000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
747000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3427000 usd
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
512000 usd
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2915000 usd
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
544000 usd
CY2022Q2 yten Operating Lease Liability Noncurrent Excluding Lease Included On Balance Sheet
OperatingLeaseLiabilityNoncurrentExcludingLeaseIncludedOnBalanceSheet
2371000 usd
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
151000 usd
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
151000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
303000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
303000 usd
CY2022Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
183000 usd
CY2021Q2 us-gaap Short Term Lease Cost
ShortTermLeaseCost
169000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
332000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
326000 usd
CY2022Q2 us-gaap Sublease Income
SubleaseIncome
153000 usd
CY2021Q2 us-gaap Sublease Income
SubleaseIncome
146000 usd
us-gaap Sublease Income
SubleaseIncome
295000 usd
us-gaap Sublease Income
SubleaseIncome
320000 usd
CY2022Q2 us-gaap Lease Cost
LeaseCost
181000 usd
CY2022Q2 yten Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
1071453 shares
CY2021Q2 us-gaap Lease Cost
LeaseCost
174000 usd
us-gaap Lease Cost
LeaseCost
340000 usd
us-gaap Lease Cost
LeaseCost
309000 usd
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y4M24D
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y10M24D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0725
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0725
CY2022Q2 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
22213 sqft
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3427000 usd
CY2020Q4 yten Collaborative Arrangement Term
CollaborativeArrangementTerm
P2Y
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
103000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
174000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
252000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
370000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
895000 usd
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
949000 usd
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1290273 shares
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
3856000 usd
CY2022Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
2294407 shares
CY2021Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
3093921 shares

Files In Submission

Name View Source Status
0001121702-22-000039-index-headers.html Edgar Link pending
0001121702-22-000039-index.html Edgar Link pending
0001121702-22-000039.txt Edgar Link pending
0001121702-22-000039-xbrl.zip Edgar Link pending
ex-311x20220630.htm Edgar Link pending
ex-312x20220630.htm Edgar Link pending
ex-321x20220630.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
yten-20220630.htm Edgar Link pending
yten-20220630.xsd Edgar Link pending
yten-20220630_def.xml Edgar Link unprocessable
yten-20220630_lab.xml Edgar Link unprocessable
yten-20220630_pre.xml Edgar Link unprocessable
yten-20220630_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
yten-20220630_cal.xml Edgar Link unprocessable